couter

Oct 15, 2026 — Strategic Financing / Equity Dilution
Chart by TradingView

The schedule

  • Thu15Oct

    Given the massive capital shortfall and negative equity, SANT must secure external financing to maintain any semblance of operations. An emergency capital raise will likely be highly dilutive, dropping shares to the $0.0001 fallback, while a strategic partnership or non-dilutive bridge could support a bounce to $0.05.

  • Fri13Nov
  • Wed20Jan

    Extended periods of poor reporting and insolvency increase the risk of an SEC trading suspension or OTC Pink downgrade. Curing these technical deficiencies could provide a brief speculative relief rally to $0.02, but failure to comply will likely crush the remaining equity value toward $0.0002.

  • Fri12Feb
  • Wed31Mar

    The FY 2026 results will confirm whether the company has navigated its insolvency or completely collapsed. A miraculous restructuring or shell reverse-merger could yield a spike to $0.005, but the default assumption of total capital destruction points to a terminal value of $0.0005.

  • Fri14May
  • Fri13Aug

Past

  • Fri14Aug

    Actual outcome: Bear · $0.00 at outcome

    SANT reported Q2 2026 EPS of -$0.0015, meeting estimates, but shares collapsed to $0.00, breaching the $0.03 bear floor. The company's severe liquidity constraints and failure to secure a viable restructuring or cash infusion confirmed going-concern fears, ultimately wiping out the equity.

    SANT faces severe liquidity constraints with only $404 in cash reported in the latest available financials. The Q2 2026 earnings release will be a critical test of going-concern viability, where a positive surprise or restructuring update could see shares test $0.10, but continued delinquency or extreme cash burn will likely push the stock down to $0.03.